These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 33299888)

  • 1. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
    Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
    Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
    Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
    Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
    [No Abstract]   [Full Text] [Related]  

  • 3. MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.
    Chen Y; Chen S; Lu J; Yuan D; He L; Qin P; Tan H; Xu L
    Medicine (Baltimore); 2021 May; 100(18):e25807. PubMed ID: 33950983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.
    Lauber C; Correia N; Trumpp A; Rieger MA; Dolnik A; Bullinger L; Roeder I; Seifert M
    Sci Rep; 2020 Jul; 10(1):12761. PubMed ID: 32728112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
    Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
    Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients.
    El Gammal MM; Ebid GT; Madney YM; Abo-Elazm OM; Kelany AK; Torra OS; Radich JP
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e281-e290. PubMed ID: 30926392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway.
    Cai X; Liu Y; Li H; Que Y; Xiao M; Wang Y; Wang X; Li D
    Ann Hematol; 2024 Jul; 103(7):2311-2322. PubMed ID: 38519605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation.
    Que Y; Li H; Lin L; Zhu X; Xiao M; Wang Y; Zhu L; Li D
    Front Immunol; 2021; 12():653030. PubMed ID: 34093541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT3A R882 mutation is associated with elevated expression of MAFB and M4/M5 immunophenotype of acute myeloid leukemia blasts.
    Yang L; Liu Y; Zhu L; Xiao M
    Leuk Lymphoma; 2015; 56(10):2914-22. PubMed ID: 25721756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.
    Ribeiro AF; Pratcorona M; Erpelinck-Verschueren C; Rockova V; Sanders M; Abbas S; Figueroa ME; Zeilemaker A; Melnick A; Löwenberg B; Valk PJ; Delwel R
    Blood; 2012 Jun; 119(24):5824-31. PubMed ID: 22490330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognosis analysis of
    Zhang TJ; Zhang LC; Xu ZJ; Zhou JD
    Aging (Albany NY); 2020 Jun; 12(14):14677-14690. PubMed ID: 32597790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
    Huang R; Liao X; Li J; Wei J; Su X; Lai X; Liu B; Zhu F; Huang Y; Li Q
    Oncol Rep; 2019 May; 41(5):2876-2888. PubMed ID: 30896832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
    Ardestani MT; Kazemi A; Chahardouli B; Mohammadi S; Nikbakht M; Rostami S; Jalili M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
    Turk J Haematol; 2018 Aug; 35(3):158-167. PubMed ID: 29786546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia.
    Jost E; Lin Q; Weidner CI; Wilop S; Hoffmann M; Walenda T; Schemionek M; Herrmann O; Zenke M; Brümmendorf TH; Koschmieder S; Wagner W
    Leukemia; 2014 Jun; 28(6):1227-34. PubMed ID: 24280869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNMT3A mutations in Chinese childhood acute myeloid leukemia.
    Li W; Cui L; Gao C; Liu S; Zhao X; Zhang R; Zheng H; Wu M; Li Z
    Medicine (Baltimore); 2017 Aug; 96(31):e7620. PubMed ID: 28767575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations.
    Kumar D; Mehta A; Panigrahi MK; Nath S; Saikia KK
    Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):82-89. PubMed ID: 29079128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent DNMT3A mutation burden in DNMT3A mutated adult cytogenetically normal acute myeloid leukemia patients in long-term remission.
    Sun Y; Shen H; Xu T; Yang Z; Qiu H; Sun A; Chen S; Wu D; Xu Y
    Leuk Res; 2016 Oct; 49():102-7. PubMed ID: 27626217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key pathways and genes in
    Huang R; Liao X; Li Q
    Onco Targets Ther; 2018; 11():163-173. PubMed ID: 29343974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.